Stock & Company Details
Enlivex Therapeutics Ltd $ENLV
Price:
46,691,331
17M
$71M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
ENLV technical indicators
Latest Enlivex Therapeutics Ltd (ENLV) technical indicators as of 2026-07-27: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
59.66 0.8%
MACD:
0.89 7.8%
SMA 50:
$1.88 3.9%
SMA 200:
$1.21 1.3%
EMA 20:
$3.78 1.4%
Bollinger Bands:
8.51 / -1.24
Stochastic:
53.31 2.8%
ADX 14:
38.10 3.1%
ATR 14:
0.57 3.5%
CCI 20:
15.95 25.3%
OBV:
196.25M 0.0%
ROC 12:
-42.43% 105.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Finance Bot
Ask your questions
Start by typing a question below.
